VV261
Fever with Thrombocytopenia Syndrome (Novel Bunyavirus)
Phase 1Active (IND Approved)
Key Facts
Indication
Fever with Thrombocytopenia Syndrome (Novel Bunyavirus)
Phase
Phase 1
Status
Active (IND Approved)
Company
About Vigonvita
A Chinese biopharma company with a fully integrated platform developing and commercializing drugs for viral infections, neuropsychiatry, and reproductive health.
View full company profile